Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, F.C.P.S. (Medicine)., F.C.P.S (Infectious Diseases)
Internal Medicine Specialist
MBBS, F.C.P.S. (Medicine)., F.C.P.S (Infectious Diseases)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Med), M.R.C.P (UK)
Hepatologist
M.B.B.S, F.C.P.S (Gastroenterology)
Diabetologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Gastroenterologist
M.B.B.S, M.D (Gastroenterology)
Gastroenterologist
MBBS, MRCP (UK), FCPS (Gastroenterology), M.D (USA), Gastroenterology SCE (UK) , European Board of Gastroenterology and Hepatology (EBGH)
Gastroenterologist
MBBS, MRCP (UK), FCPS (Gastroenterology), M.D (USA), Gastroenterology SCE (UK) , European Board of Gastroenterology and Hepatology (EBGH)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures